Kaiser Permanente Ventures β 2021 Investments
4 investments dated 2021 Β· listed companies and verified rows first Β· show all
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Co-investorsCoatue ManagementMorningside Venture Capital LimitedQiming Venture PartnersSoftBank Vision FundBoyu CapitalGL Ventures+6 more
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtech
Mark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)inMonica Zarb(Vice President, Business Development)inDurand Van Arnem(Vice President, Engineering)inAlan Rope(Medical Director)in
Co-investorsCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)Illumina VenturesPearl Abyss Capital+7 more
Ginger is an AI-powered grammar and spell checker for the English language, using machine learning and language models to correct and improve writing.
AI & Machine LearningEdTechSaaS
Co-investorsJerusalem Global VenturesBessemer Venture PartnersBlackstoneCity LightHealth Velocity CapitalKhosla Ventures+3 more
Groups provides medication-assisted treatment for opioid and substance use disorder, offering Suboxone treatment through in-person and virtual programs that accept insurance and Medicaid.
Digital HealthHealthtech
Co-investorsBessemer Venture PartnersOak HC/FTOptum VenturesRRE Ventures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.















